A Phase 3 Study of CPX-351 versus Conventional 7+3...

Clinical Lymphoma Myeloma and Leukemia 2018 / 09 Vol. 18

A Phase 3 Study of CPX-351 versus Conventional 7+3 Cytarabine and Daunorubicin: Subanalysis of Patients with Secondary Acute Myeloid Leukemia (sAML) with Refractory Anemia with Excess of Blasts in Transformation (RAEB-t)

Lin, Tara L., Wieduwilt, Matthew J., Newell, Laura F., Schiller, Gary J., Rubenstein, S. Eric, Stock, Wendy, Warlick, Erica, Bixby, Dale L., Podoltsev, Nikolai, An, Qi, Faderl, Stefan, Louie, Arthur C
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
18
Language:
english
Journal:
Clinical Lymphoma Myeloma and Leukemia
DOI:
10.1016/j.clml.2018.07.063
Date:
September, 2018
File:
PDF, 66 KB
english, 2018
Conversion to is in progress
Conversion to is failed